Big Pharma

Medication Rationing UK Amid Shortages

Please Note: Drug shortages can vary over time due to a range of factors including manufacturing issues, regulatory challenges, supply chain disruptions, and changes in demand. Community Pharmacy England or the UK’s Department of Health and Social Care may provide up-to-date information on drug shortages in the UK. Checking their official websites or contacting them directly would be the best way to obtain the most current information on drug shortages in the UK.

AstraZeneca Withdraws COVID Vaccine Worldwide

In a significant development, pharmaceutical giant AstraZeneca has announced the worldwide withdrawal of its COVID-19 vaccine. The decision comes in the wake of mounting concerns over rare cases of blood clotting associated with the vaccine.

MHRA Cracks Down on Advertising for Steroid-based Drug Kenalog

As the MHRA tightens its oversight of Kenalog advertising, it sends a clear message that the promotion of medications must prioritize patient safety above all else. By fostering transparency and accountability in pharmaceutical marketing, regulatory authorities can help safeguard the well-being of individuals who rely on these medications for their health needs.

The Controversy Of Kobayashi Pharmaceutical Company

The unfolding tragedy traces its origins back to the delayed actions of Kobayashi Pharmaceutical Co, which is now under intense scrutiny for its failure to promptly address internal concerns dating as far back as January.

ZB001 for the Treatment of Thyroid Eye Disease

Thyroid eye disease (TED), also known as Graves ophthalmopathy, is an autoimmune disorder that affects the eyes and is associated with hyperthyroidism.

ZB001

ZB001 also known as the “miracle drug,” is a new breakthrough in the world of medicine. It is an experimental medication that has shown remarkable efficacy against a wide range of viruses, including influenza, HIV, and coronaviruses such as SARS-CoV-2.

Obexelimab and What it Means for Autoimmune Disorders?

Obexelimab is a novel monoclonal antibody that is currently under investigation for the treatment of various autoimmune disorders. This medication works by binding to a protein called CD6, which is found on the surface of T cells in the immune system.